About
Basic Data Updated:
14 days agoConcord Drugs Limited, founded in 1995, is a company that specializes in the production of bulk drugs and active pharmaceutical intermediates. These products are manufactured at two state-of-the-art facilities, one situated in Brahmanapally village, Telangana, which produces injections and pellets, and the other located in Uttarakand, which focuses on tablets and capsules. The company takes great pride in its GMP quality certification, ensuring that all products meet the highest standards of quality and safety. S Nagi Reddy, the founder of CDL, has played a pivotal role in the company's success and growth. His vision and leadership have propelled the company to become a prominent player in the pharmaceutical industry. As a testament to its success, CDL is listed on the Bombay Stock Excha... Read More
Industry
Company Details
- LocationNa, Telangana
- Website1222442
- Telephone1222442
- Email Address1222442
- Social Media1222442
| CIN/LLPIN/FCRN | L24230TG1995PLC020093 |
| Company No. | 020093 |
| Stock Symbol | BSE : 538965 |
| Company Classification | Public Limited Indian Non-Government Company |
| Incorporation Date | 24 Apr 1995 |
| Date of AGM | 30 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Listed |
| ROC Code | Roc Hyderabad |
Products or Services related to Concord Drugs Limited
Alcohol Based Hand Sanitizer
Financials of Concord Drugs Limited
Concord Drugs Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 14.78% increase. The company also saw a substantial fall in profitability, with a 51.42% decrease in profit. The company's net worth moved up by a moderate rise of 5.96%.
Enhance accessibility to Concord Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Concord Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Concord Drugs Limited
Unlock and access historical data on people associated with Concord Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
Koni Seelam
CFOAppointment Date: 30-Mar-2015
Status: Current
NS
Nagi Seelam Managing DirectorAppointment Date: 04-Apr-2003
Status: Current
N
Namratha Company SecretaryAppointment Date: 08-Apr-2024
Status: Current
Board Members(5)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 17 Dec 2011 | ₹16.72 Cr | Open |
Others Creation Date: 11 Mar 2022 | ₹5.00 Cr | Satisfied |
Punjab National Bank Creation Date: 10 Nov 2005 | ₹1.40 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Concord Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Concord Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Proton Remedies Private Limited
Active
15 years 7 months Koni Seelam and Seelam Manojkumarreddy are mutual person
Cortex Laboratories Private Limited
Active 28 years 11 months Seelam Manojkumarreddy is a mutual person
Seelam Laboratories Private Limited
Active 13 years 11 months Seelam Manojkumarreddy is a mutual person
Continental Pellets Pharma Private Limited
Active 4 years 2 months Seelam Manojkumarreddy is a mutual person
Recent activity within the organization
Director Appointment
Namratha was appointed as a Company Secretary was appointed as a Company Secretary on 08 Apr 2024 & has been associated with this company since 28 days .
08 Apr 2024Annual General Meeting
Concord Drugs Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
30 Sep 2023Charges
A charge registered on 11 Mar 2022 via Charge ID 100568210 with Others was fully satisfied on 18 Apr 2023.
18 Apr 2023Balance Sheet
Concord Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
31 Mar 2023Charges
A charge with Others amounted to Rs. 5.00 cr with Charge ID 100568210 was registered on 11 Mar 2022.
11 Mar 2022
Frequently asked questions
What is the Incorporation or founding date of Concord Drugs Limited?
